Skip to content

Optimization of post-hospital intensive care for neurological patients

Optimization of post-hospital intensive care for neurological patients - OptiNIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027326
Enrollment
173
Registered
2022-01-18
Start date
2022-02-28
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G00-G99 Z99.0

Interventions

Group 1: Intervention group: receives new form of care with additional assessments, team conferences, and feedback, and if possible, inpatient assessment and interval rehabilitation as a follow-up. Gr

Sponsors

Klinikum der Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age of majority - Inpatient treatment in the neurological early rehabilitation with neurological rehabilitation diagnosis - Presence of mechanical ventilation and/or TC. - Acute onset of illness < 10 months - Planned discharge to AIP in Bavaria - Existing informed consent for study participation

Exclusion criteria

Exclusion criteria: - Palliative treatment/life expectancy according to medical assessment < 12 months - Weaning/decanulation medically ruled out (e.g., high cervical spinal cord injury, laryngeal tumor) - Pre-existing AIP - Progressive neuromuscular disease (e.g. Muscular dystrophy, ALS)

Design outcomes

Primary

MeasureTime frame
Rate of patients in the intervention group compared to the control group who could be weaned from mechanical ventilation and/or TC one year after the start of treatment in the AIP

Secondary

MeasureTime frame
Clinical factors (standardized scores using questionnaires and clinical scales, respectively): TC and ventilatory status and modalities. Mortality Neurological status Activities of daily living (ATL) Quality of life (QOL)/depression, anxiety Relative burden Care situation Satisfaction with care situation (use of AIP / living arrangements) Utilization of health care (medication, remedies, hospital treatment) Complications/side effects Additional health economic factors: Indirect and direct costs of the intervention Analysis of pseudonymized AOK routine data Cost-benefit analysis of the new form of treatment

Countries

Germany

Contacts

Public ContactAndreas Bender

Neurologische Klinik, Klinikum der Universität München

anbender@med.uni-muenchen.de089440074833

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026